Michael Klichinsky - Net Worth and Insider Trading
Michael Klichinsky Net Worth
The estimated net worth of Michael Klichinsky is at least $0 dollars as of 2026-07-28. Michael Klichinsky is the Chief Scientific Officer of CARISMA Therapeutics Inc and owns about 0 shares of CARISMA Therapeutics Inc (CARM) stock worth over $0. Details can be seen in Michael Klichinsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Klichinsky has not made any transactions after 2025-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Klichinsky
Michael Klichinsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Klichinsky owns 2 companies in total, including Sesen Bio Inc (SESN) , and CARISMA Therapeutics Inc (CARM) .
Click here to see the complete history of Michael Klichinsky’s form 4 insider trades.
Insider Ownership Summary of Michael Klichinsky
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SESN | Sesen Bio Inc | 2023-03-07 | Chief Scientific Officer |
| CARM | CARISMA Therapeutics Inc | 2025-10-07 | Chief Scientific Officer |
Michael Klichinsky Latest Holdings Summary
Michael Klichinsky currently owns a total of 1 stock. Michael Klichinsky owns 0 shares of CARISMA Therapeutics Inc (CARM) as of October 7, 2025, with a value of $0.
Latest Holdings of Michael Klichinsky
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARM | CARISMA Therapeutics Inc | 2025-10-07 | 0 | 0.00 | 0 |
Holding Weightings of Michael Klichinsky
Michael Klichinsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Klichinsky has made a total of 2 transactions in CARISMA Therapeutics Inc (CARM) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CARISMA Therapeutics Inc is the sale of 56,982 shares on October 7, 2025, which brought Michael Klichinsky around $14,246.
Insider Trading History of Michael Klichinsky
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Michael Klichinsky Trading Performance
Michael Klichinsky Ownership Network
Ownership Network List of Michael Klichinsky
Ownership Network Relation of Michael Klichinsky
Michael Klichinsky Owned Company Details
What does Sesen Bio Inc do?
Who are the key executives at Sesen Bio Inc?
Michael Klichinsky is the Chief Scientific Officer of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .
Sesen Bio Inc (SESN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sesen Bio Inc Insider Transactions
Michael Klichinsky Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Klichinsky. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael Klichinsky's mailing address is: Philadelphia Pa 19104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
